The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Polivy (polatuzumab vedotin)
Australian Public Assessment Report
Device/Product Name
Polivy
Active ingredients
Polatuzumab vedotin
AusPAR Date
Published
Sponsor
Submission Number
PM-2021-05903-1-6
Submission Type
Extension of indications
Decision
Approved